Suvretta Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-123,774	Closed	-$7.36M	–	117
2020 Q3	$7.36M	Buy	+123,774	New	+$7.36M	0.13%	58